Search research articles
Contact Us
Filters
Showing results (91-100 of 110) with videos related to
Page
of 11
Sort By:
International Journal of Cancer
|
September 13, 2014
DNA methylation array analyses identified breast cancer-associated HYAL2 methylation in peripheral blood
Rongxi Yang, Katrin Pfütze, Manuela Zucknick, et al.
Cell Calcium
|
November 28, 2025
Fura-10, unlike fura-2, is suitable for long-term calcium imaging in natural killer (NK) cells without compromising cytotoxicity and can be combined with target cell death analysis
Lea Kaschek, Joanne Vialle, Gebhard Stopper, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
September 18, 2025
Restoring NK Cell Cytotoxicity Post-Cryopreservation via Synthetic Cells
Xiangda Zhou, Sijia Zhang, Wenjuan Yang, et al.
Nature Communications
|
August 30, 2018
AXER is an ATP/ADP exchanger in the membrane of the endoplasmic reticulum
Marie-Christine Klein, Katharina Zimmermann, Stefan Schorr, et al.
Cellular and Molecular Life Sciences : CMLS
|
February 15, 2016
Deep characterization of blood cell miRNomes by NGS
Eva C Schwarz, Christina Backes, Arne Knörck, et al.
Frontiers in Immunology
|
March 10, 2022
Unspecific CTL Killing Is Enhanced by High Glucose <i>via</i> TNF-Related Apoptosis-Inducing Ligand
Wenjuan Yang, Andreas Denger, Caroline Diener, et al.
Cancer Cell
|
June 15, 2013
Overcoming intrinsic multidrug resistance in melanoma by blocking the mitochondrial respiratory chain of slow-cycling JARID1B(high) cells
Alexander Roesch, Adina Vultur, Ivan Bogeski, et al.
Nature Communications
|
September 13, 2017
NFATc1 controls the cytotoxicity of CD8<sup>+</sup> T cells
Stefan Klein-Hessling, Khalid Muhammad, Matthias Klein, et al.
Oncotarget
|
September 1, 2016
DNA methylation array analysis identifies breast cancer associated RPTOR, MGRN1 and RAPSN hypomethylation in peripheral blood DNA
Qiuqiong Tang, Tim Holland-Letz, Alla Slynko, et al.
The Lancet. Haematology
|
February 3, 2022
KIR2DS1-HLA-C status as a predictive marker for benefit from rituximab: a post-hoc analysis of the RICOVER-60 and CLL8 trials
Dominic Kaddu-Mulindwa, Bettina Altmann, Sandra Robrecht, et al.
Page
of 11
Search research articles
Search
Showing results (91-100 of 110) with videos related to
Sort By:
Page
of 11
International Journal of Cancer
|
September 13, 2014
DNA methylation array analyses identified breast cancer-associated HYAL2 methylation in peripheral blood
Rongxi Yang, Katrin Pfütze, Manuela Zucknick, et al.
Cell Calcium
|
November 28, 2025
Fura-10, unlike fura-2, is suitable for long-term calcium imaging in natural killer (NK) cells without compromising cytotoxicity and can be combined with target cell death analysis
Lea Kaschek, Joanne Vialle, Gebhard Stopper, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
September 18, 2025
Restoring NK Cell Cytotoxicity Post-Cryopreservation via Synthetic Cells
Xiangda Zhou, Sijia Zhang, Wenjuan Yang, et al.
Nature Communications
|
August 30, 2018
AXER is an ATP/ADP exchanger in the membrane of the endoplasmic reticulum
Marie-Christine Klein, Katharina Zimmermann, Stefan Schorr, et al.
Cellular and Molecular Life Sciences : CMLS
|
February 15, 2016
Deep characterization of blood cell miRNomes by NGS
Eva C Schwarz, Christina Backes, Arne Knörck, et al.
Frontiers in Immunology
|
March 10, 2022
Unspecific CTL Killing Is Enhanced by High Glucose <i>via</i> TNF-Related Apoptosis-Inducing Ligand
Wenjuan Yang, Andreas Denger, Caroline Diener, et al.
Cancer Cell
|
June 15, 2013
Overcoming intrinsic multidrug resistance in melanoma by blocking the mitochondrial respiratory chain of slow-cycling JARID1B(high) cells
Alexander Roesch, Adina Vultur, Ivan Bogeski, et al.
Nature Communications
|
September 13, 2017
NFATc1 controls the cytotoxicity of CD8<sup>+</sup> T cells
Stefan Klein-Hessling, Khalid Muhammad, Matthias Klein, et al.
Oncotarget
|
September 1, 2016
DNA methylation array analysis identifies breast cancer associated RPTOR, MGRN1 and RAPSN hypomethylation in peripheral blood DNA
Qiuqiong Tang, Tim Holland-Letz, Alla Slynko, et al.
The Lancet. Haematology
|
February 3, 2022
KIR2DS1-HLA-C status as a predictive marker for benefit from rituximab: a post-hoc analysis of the RICOVER-60 and CLL8 trials
Dominic Kaddu-Mulindwa, Bettina Altmann, Sandra Robrecht, et al.
Page
of 11